Drug Database
CA

carteolol hydrochloride + latanoprost (Mikeluna / OPC 1085EL / OPC1085EL)

✓ Approved

Senju · ADRB1

什么是 carteolol hydrochloride + latanoprost?

carteolol hydrochloride + latanoprost 是一种治疗药物,由Senju研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

商品名Mikeluna, OPC 1085EL, OPC1085EL
公司Senju
分子靶点ADRB1, ADRB2
给药途径Others
状态Approved

作用机制

分子靶点

carteolol hydrochloride + latanoprost 作用于 2 个分子靶点:

ADRB1adrenoceptor beta 1 (B1AR, RHR)
ADRB2adrenoceptor beta 2 (B2AR, ADRBR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

carteolol hydrochloride + latanoprost 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Eye disordersGlaucoma✓ Approved

相关研究文献

PubMedClinical oral investigations2026-11-19

Intra-sulcular compound chamomile and lidocaine hydrochloride gel for procedural pain during ultrasonic scaling: a randomized, single-blind, split-mouth, sham-controlled superiority trial in adults with plaque-induced gingivitis.

Tang Rong R, Yin Tingting T, Liang Jia J, Wang Ruijie R et al.

This study aimed to evaluate whether intra-sulcular application of a compound chamomile and lidocaine hydrochloride gel (Kami-Gel) reduces procedural pain during ultrasonic supragingival scaling in adults with plaque-induced gingivitis compared with a sham procedure. A single-center, randomized, single-blind, split-mouth, sham-controlled superiority trial was conducted involving 114 adults with plaque-induced gingivitis. Participants received a sequential split-mouth treatment. The test side received intra-sulcular application of Kami-Gel, while the control side received a sham application (mimicked injection). The primary outcome was procedural pain intensity measured on a 0-10 Visual Analog Scale (VAS). Secondary outcomes included the number of pain complaints, procedural duration, patient satisfaction, and plaque index (PI). Safety was assessed immediately and at 24 h. All 114 participants completed the study. Median VAS score was significantly lower in the test group (1.7 [IQR: 0.62-2.58]) than the control group (4.1 [IQR: 2.42-5.7]), with an estimated treatment difference of - 2.35 (95% CI: -3.0 to - 1.7)-the upper limit of which fell below the pre-specified superiority margin of - 1.2, confirming superiority (P < 0.001). The test group also demonstrated significantly fewer pain complaints (median 0 vs. 1), shorter procedural duration (median 10 vs. 12 min), and higher patient satisfaction (all P < 0.001). Post-scaling plaque index was significantly lower in the test group (median 0.75 [IQR: 0.55-0.86] vs. 0.89 [IQR: 0.75-0.96]; P < 0.001), though this difference may reflect improved patient cooperation rather than a direct pharmacological effect. No adverse events were reported. Intra-sulcular application of compound chamomile and lidocaine hydrochloride gel reduces procedural pain during ultrasonic supragingival scaling compared to a sham procedure. Its use was associated with shorter active scaling time and higher satisfaction. Whether these acute benefits translate to improved long-term periodontal treatment compliance warrants further investigation. Intra-sulcular application of compound chamomile and lidocaine gel (Kami-Gel) prior to ultrasonic supragingival scaling reduces procedural pain and was associated with higher patient satisfaction. A lower post-scaling plaque index was observed in the test group, potentially attributable to improved patient cooperation during instrumentation. This safe, non-injectable chairside technique provides clinicians a practical tool to enhance patient comfort during scaling procedures.

PMID 43052462
阅读全文 →
PubMedBMC oral health2026-11-19

Antibacterial efficacy of octenidine, sodium hypochlorite, and their combination against multispecies endodontic biofilms: an in vitro CLSM study.

Baştürk Özer Muazzez Naz MN, Çulha Emre E, Özer Hasan Yıldırım HY

The current study used confocal laser scanning microscopy (CLSM) to assess the antibacterial activity of octenidine hydrochloride (OCT) both by itself and in combination with sodium hypochlorite (NaOCl) on the eradication of biofilms. Forty dentin blocks were inoculated with a biofilm consisting of Enterococcus faecalis, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus mutans. After a 3-week incubation period, the resulting diverse biofilm was imaged using a scanning electron microscope (SEM). Five groups were formed: Saline solution (SS), 2% chlorhexidine (CHX), 5% NaOCl, undiluted OCT (containing 0.1% octenidine), and a 5% NaOCl / undiluted OCT mixture (90:10 ratio). Samples were subjected to the relevant agent for 5 min. The percentage of dead cell bacteria was evaluated using the Live/Dead BacLight Viability Kit dye under CLSM. Image analysis was performed with Image J software. The Kruskal-Wallis and Dunn's tests were used to statistically assess the data, with a significance threshold of p < 0.05. CLSM images showed that the NaOCl alone eliminated the amount of bacteria similar to NaOCl/OCT mixture group (p > 0.05) and significantly more bacteria compared to other solutions (p < 0.05). NaOCl/OCT mixture group was also similar to the OCT alone group (p > 0.05), while CHX and SS groups represented the least amount of dead bacteria than other groups (p < 0.05). Under the experimental conditions, the NaOCl/OCT combination demonstrated antibacterial activity comparable to NaOCl alone. While 5% NaOCl remained the most effective agent, the addition of OCT did not provide a statistically significant increase in antibacterial efficacy. SS and CHX exhibited significantly lower antibacterial effects.

PMID 43052949
阅读全文 →
PubMedExpert opinion on drug safety2026-11-18

Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia.

Holló Gábor G

This post hoc analysis of MERCURY-3 evaluates factors associated with baseline ocular hyperemia and tolerability outcomes with netarsudil/latanoprost fixed combination (NET/LAT). MERCURY-3 was a prospective, randomized, double-masked, multicenter, Phase 3, European trial. Adults with open-angle glaucoma or ocular hypertension inadequately controlled on topical therapy were randomized to once-daily NET/LAT (n = 218) or bimatoprost/timolol fixed combination (BIM/TIM; n = 212) for 6 months. Patients were stratified by baseline ocular hyperemia status (none vs any grade) and associations with prior treatment, adverse events (AEs), and hyperemia evolution evaluated. In the NET/LAT arm, prior combination therapy was associated with a greater prevalence of baseline ocular hyperemia than prior monotherapy (distribution: p = 0.003). Patients with baseline hyperemia experienced higher rates of AEs (85% vs 63%), ocular treatment-related AEs (74% vs 39%), and conjunctival hyperemia (45% vs 26%) during treatment. Ocular hyperemia remained predominantly mild throughout follow-up, with a more stable severity trajectory linked to prior monotherapy compared with prior combination therapy. No comparable associations were observed with BIM/TIM. Prior treatment complexity and baseline ocular hyperemia status are associated with tolerability outcomes during NET/LAT therapy. These exploratory findings suggest that earlier step-up after monotherapy could be associated with more favorable tolerability. CT.gov identifier: NCT03284853.

PMID 43046532
阅读全文 →
PubMedFrontiers in aging2026-11-18

Effect of papaverine hydrochloride on functional visual acuity in non-arteritic central retinal artery occlusion: a retrospective cohort study.

Liu Zhongzhong Z, Lu Qingli Q, Liu Tong T, Peng Linna L et al.

Non-arteritic central retinal artery occlusion (NA-CRAO) is an acute ocular emergency that frequently results in severe and irreversible vision loss with limited therapeutic options. Papaverine hydrochloride, a non-specific vasodilator commonly used to relieve vasospasm, has not been previously evaluated for its potential benefits for visual recovery in patients with NA-CRAO. Therefore, this study aims to investigate the association between papaverine hydrochloride treatment (PHt) and functional visual acuity improvement in patients with NA-CRAO. Propensity-score matching was used to retrospectively collect clinical data of 104 NA-CRAO patients with similar baseline characteristics. The patients were categorized into a PHt group (n = 52) and a non-papaverine hydrochloride treatment (non-PHt) group (n = 52). The primary outcome was functional visual acuity (best-corrected visual acuity ≥20/100) assessed at discharge and at a 1-month follow-up. Logistic regression and subgroup analyses were performed to evaluate the associations between papaverine hydrochloride use and improvements in functional visual acuity. The PHt group showed significantly higher functional visual acuity than the non-PHt group at discharge (32.7% vs. 15.4%, p = 0.039) and at the 1-month follow-up (53.8% vs. 34.6%, p = 0.048). In adjusted models, treatment with papaverine hydrochloride was an independent favorable factor for improved functional visual acuity at discharge (odds ratio [OR] = 3.52, 95% confidence interval [CI]: 1.20-10.36, p = 0.022) and at the 1-month follow-up (OR = 3.15, 95% CI: 1.19-8.29, p = 0.020). Subgroup analyses demonstrated consistent therapeutic effects across age, sex, the side of the affected eye, intra-arterial thrombolysis and intravenous thrombolysis strata, with no statistically significant interaction effects identified at either time point (all Pinteraction >0.05). Treatment with papaverine hydrochloride was significantly associated with visual recovery in patients with NA-CRAO. Prospective further studies of causality are needed to validate these results and assess their safety.

PMID 43047374
阅读全文 →
PubMedVestnik otorinolaringologii2026-11-18

[Possibilities of topical therapy of acute bullous otitis media].

Baranov K K KK, Vyazmenov E O EO, Kotova E N EN, Polunin M M MM et al.

Bullous myringitis is a borderline condition between inflammatory processes of the external and middle ear. The aim was to evaluate the comparative efficacy of three combined topical preparations in complex treatment of acute bullous otitis media. 140 patients aged 6-40 years (110 (78.6%) children) were divided into three groups: group 1 (n=50) - chloramphenicol+clotrimazole+beclomethasone dipropionate+lidocaine hydrochloride; group 2 (n=45) - phenazone+lidocaine; group 3 (n=45) - neomycin+polymyxin B+dexamethasone. Pain relief was fastest in group 2 (by day 3); otoscopic signs resolved by day 5, with the best combined results in group 1. In 25-28 (17.9-20.0%) patients bullous otitis was associated with PCR-confirmed influenza A (H1N1); Mycoplasma pneumoniae was detected in 4 (2.9%). The incidence peaked in December-February.

PMID 43046736
阅读全文 →
PubMedFood research international (Ottawa, Ont.)2026-11-18

Multidimensional profiling of bitterness responsiveness reveals distinct response profiles beyond PROP status.

Ko Doeun D, Noh Seo-Jung SJ, Chang U-Ju UJ, Kim Minji M et al.

Bitterness responsiveness varies substantially among individuals and may not be adequately represented by conventional 6-n-propylthiouracil (PROP) taster status. This study characterized multidimensional responses to multiple bitter stimuli and examined their oral physiological, dietary, and genetic correlates. A total of 262 Korean women aged 20-39 years rated the bitterness of quercetin, food-grade aloe vera powder, caffeine, quinine hydrochloride, and PROP using the general Labeled Magnitude Scale once per stimulus in each of three weekly sessions. Z-score-standardized mean ratings were analyzed using agglomerative hierarchical clustering. Internal validation and resampling stability supported two groups with higher or lower overall bitterness ratings. Five exploratory subgroups described stimulus-specific patterns within these groups. One subgroup had relatively low PROP ratings but elevated ratings for several other stimuli; another had the lowest mean ratings for most other stimuli but not for PROP. Fungiform and circumvallate papillae counts, and total salivary protein concentration did not differ significantly between the two groups or between the latter subgroup and the remaining participants after false discovery rate correction. No dietary differences remained significant in overall comparisons between the two groups or five subgroups; however, in an exploratory comparison, the latter subgroup reported more frequent coffee consumption than the remaining participants (adjusted p = 0.0057). In the genotyped subset (n = 174; n = 172 for common-diplotype comparisons), TAS2R38 diplotype associations remained significant only for PROP after correction. In the full sensory cohort, PROP status alone did not capture the full range of bitterness-response patterns. The five subgroups remain exploratory and require independent replication.

PMID 43051771
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多carteolol hydrochloride + latanoprost